Covid19
Unpersuaded by the data, FDA rejects cheap, generic SSRI as a Covid-19 drug – Endpoints News
Fluvoxamine, an SSRI already FDA-approved as an OCD treatment, appeared to show some hints of efficacy in Covid-19 too, leading University of …
Fluvoxamine, an SSRI already FDA-approved as an OCD treatment, appeared to show some hints of efficacy in Covid-19 too, leading University of …